Blend ratio 5 : 1 : 1 (GHK-Cu : TB-500 : BPC-157) GHK-Cu dominant 70 mg total per vial: 50 mg GHK-Cu, 10 mg TB-500, and 10 mg BPC-157
Here are two of the most notable experiments to date: In an 11-day study, obese mice treated with 20mg/kg of 5-amino-1MQ trice daily experienced a 5.1% weight reduction from baseline, while control mice gained 1.4% in body weight
While research indicates that it does not significantly impact growth hormone levels, IGF-1, or glucose metabolism, long-term studies on its safety are still limited
Sublingual B12 bypasses intestinal absorption issues and potential barriers caused by genetic variants, which makes it a more accessible treatment option for vitamin B12 deficiency
The core premise is metabolic selectivity: it activates the lipolytic machinery of fat tissue without engaging the growth hormone receptor or elevating IGF-1